Appeals Court Finds Fosamax Lawsuits Over Femur Fractures Are Not Preempted
Fosamax femur fracture lawsuits will be returned to the U.S. District Court in New Jersey, where the litigation was consolidated more than 13 years ago.
Fosamax femur fracture lawsuits will be returned to the U.S. District Court in New Jersey, where the litigation was consolidated more than 13 years ago.
The FDA rejected an effort by Merck to add new Fosamax fracture label warnings in 2009, a federal judge determined.
Both Fosamax and Actonel had similar risks of patient suffering hip fractures following a two year drug holiday, but longer holidays increased the risk of Actonel fractures, researchers found.